Search results

Grace Furman, President and CEO of Paracelsus, explores common misconceptions in IND-enabling toxicology programs and how sound regulatory toxicology supports safe, successful FIH trials.

Explore dose range finding (DRF) studies in nonclinical research, from safety assessments to pharmacokinetics and biomarkers, ensuring optimized drug development.

Beatrice Setnik, PhD, discusses the mission of CCALC, the importance of abuse potential studies, and challenges in evaluating psychedelics for clinical use.

Discover four key topics to expect to cover during your first meeting with a contract research organization, to set yourself up for a long-lasting partnership.